Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Randomized, Observer-blind, Multi-center, Noninferiority Comparison of the Immune Response of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Trivalent Inactivated Split-Virion Influenza Vaccine in a Pediatric Population Aged Greater Than or Equal to 6 Months to Less Than 18 Years.
Brief Summary: The purpose of this study is to determine the immunogenicity and safety profile of CSL Limited's Influenza Virus Vaccine compared to a US licensed comparator Influenza Virus Vaccine in a pediatric population aged greater than or equal to 6 months to less than 18 years.


Options:
A: Intervention Type: DRUG; Name: Liquid CAIV-T; Assigned to Arm(s): N/A
B: Arm Label: Influenza vaccine LAIV; Type: EXPERIMENTAL; Interventions: Biological: Trivalent Inactivated Vaccine | Arm Label: Influenza vaccine TIV; Type: ACTIVE_COMPARATOR; Interventions: Biological: Live Attenuated Influenza Vaccine | Intervention Type: BIOLOGICAL; Name: Trivalent Inactivated Vaccine; Assigned to Arm(s): Influenza vaccine LAIV | Intervention Type: BIOLOGICAL; Name: Live Attenuated Influenza Vaccine; Assigned to Arm(s): Influenza vaccine TIV
C: Arm Label: Afluria Cohort A; Type: EXPERIMENTAL; Interventions: Biological: CSL's Influenza Virus Vaccine (Afluria) | Arm Label: Afluria Cohort B; Type: EXPERIMENTAL; Interventions: Biological: CSL's Influenza Virus Vaccine (Afluria) | Arm Label: Afluria Cohort C; Type: EXPERIMENTAL; Interventions: Biological: CSL's Influenza Virus Vaccine (Afluria) | Arm Label: Fluzone Cohort A; Type: ACTIVE_COMPARATOR; Interventions: Biological: Influenza Virus Vaccine (Fluzone) | Arm Label: Fluzone Cohort B; Type: ACTIVE_COMPARATOR; Interventions: Biological: Influenza Virus Vaccine (Fluzone) | Arm Label: Fluzone Cohort C; Type: ACTIVE_COMPARATOR; Interventions: Biological: Influenza Virus Vaccine (Fluzone) | Intervention Type: BIOLOGICAL; Name: CSL's Influenza Virus Vaccine (Afluria); Assigned to Arm(s): Afluria Cohort A, Afluria Cohort B, Afluria Cohort C | Intervention Type: BIOLOGICAL; Name: Influenza Virus Vaccine (Fluzone); Assigned to Arm(s): Fluzone Cohort A, Fluzone Cohort B, Fluzone Cohort C
D: Arm Label: Influenza A (H5N1) adjuvanted 6-<36M Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus monovalent vaccine | Arm Label: Influenza A (H5N1) Virus monovalent vaccine 3-<9Y Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus monovalent vaccine | Arm Label: Influenza A (H5N1) Virus monovalent vaccine 9-<18Y Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus monovalent vaccine | Arm Label: Placebo 6-<36M Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Saline placebo | Arm Label: Placebo 3-<9Y Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Saline placebo | Arm Label: Placebo 9-<18Y Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Saline placebo | Arm Label: Placebo/Influenza A (H5N1) adjuvanted Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus monovalent vaccine | Intervention Type: BIOLOGICAL; Name: Influenza A (H5N1) Virus monovalent vaccine; Assigned to Arm(s): Influenza A (H5N1) Virus monovalent vaccine 3-<9Y Group, Influenza A (H5N1) Virus monovalent vaccine 9-<18Y Group, Influenza A (H5N1) adjuvanted 6-<36M Group, Placebo/Influenza A (H5N1) adjuvanted Group | Intervention Type: BIOLOGICAL; Name: Saline placebo; Assigned to Arm(s): Placebo 3-<9Y Group, Placebo 6-<36M Group, Placebo 9-<18Y Group

Answer: C